An Unusual Member of the Cdk Family: Cdk5

被引:0
|
作者
Fatema A. Dhariwala
Medha S. Rajadhyaksha
机构
[1] Sophia College,Department of Life Sciences
[2] Bhabha Atomic Research Center,Radiation Biology and Health Sciences Division
来源
关键词
Cdk5; Neurodevelopment; Neurodegeneration; Regulation of Cdk5; Substrates of Cdk5;
D O I
暂无
中图分类号
学科分类号
摘要
The proline-directed serine threonine kinase, Cdk5, is an unusual molecule that belongs to the well-known large family of proteins, cyclin-dependent kinases (Cdks). While it has significant homology with the mammalian Cdk2 and yeast cdc2, unlike the other Cdks, it has little role to play in cell cycle regulation and is activated by non-cyclin proteins, p35 and p39. It phosphorylates a spectrum of proteins, most of them associated with cell morphology and motility. A majority of known substrates of Cdk5 are cytoskeletal elements, signalling molecules or regulatory proteins. It also appears to be an important player in cell–cell communication. Highly conserved, Cdk5 is most abundant in the nervous system and is of special interest to neuroscientists as it appears to be indispensable for normal neural development and function. In normal cells, transcription and activity of Cdk5 is tightly regulated. Present essentially in post-mitotic neurons, its normal activity is obligatory for migration and differentiation of neurons in developing brain. Deregulation of Cdk5 has been implicated in Alzheimer’s disease, amyotrophic lateral sclerosis, Parkinson’s disease, Huntington’s disease and acute neuronal injury. Regulators of Cdk5 activity are considered as potential therapeutic molecules for degenerative diseases. This review focuses on the role of Cdk5 in neural cells as regulator of cytoskeletal elements, axonal guidance, membrane transport, synaptogenesis and cell survival in normal and pathological conditions.
引用
收藏
页码:351 / 369
页数:18
相关论文
共 50 条
  • [31] Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis
    Zheng, Ya-Li
    Zhang, Xia
    Fu, Hai-Xia
    Guo, Mei
    Shukla, Varsha
    Amin, Niranjana D.
    Jing, E.
    Bao, Li
    Luo, Hong-Yan
    Li, Bo
    Lu, Xiao-Hua
    Gao, Yong-Cai
    PLOS ONE, 2016, 11 (08):
  • [32] The regulation of Cdk5 kinase activity through the metabolism of p35 Cdk5 activator
    Hisanaga, SI
    Saito, T
    JOURNAL OF NEUROCHEMISTRY, 2004, 88 : 8 - 8
  • [33] CDK5: A Unique CDK and Its Multiple Roles in the Nervous System
    Cortes, Nicole
    Guzman-Martinez, Leonardo
    Andrade, Victor
    Gonzalez, Andrea
    Maccioni, Ricardo B.
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 68 (03) : 843 - 855
  • [34] A novel CDK5 interactor.
    Zukerberg, LR
    Vidal, M
    Tsai, LH
    LABORATORY INVESTIGATION, 1997, 76 (01) : 909 - 909
  • [35] Cdk7 functions as a Cdk5 activating kinase in brain
    Rosales, JL
    Han, BY
    Lee, KY
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2003, 13 (05) : 285 - 296
  • [36] Cdk5 substrates in neutrophil granules
    Rosales, JL
    Kycia, KK
    Ernst, JD
    Lee, KY
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 502A - 502A
  • [37] Inhibition of CDK5 in colorectal cancer
    Robb, Caroline M.
    CANCER RESEARCH, 2015, 75
  • [38] Mechanism of CDK5/p25 binding by CDK inhibitors
    Mapelli, M
    Massimiliano, L
    Crovace, C
    Seeliger, MA
    Tsai, LH
    Meijer, L
    Musacchio, A
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (03) : 671 - 679
  • [39] CDK5 A new lead to survival
    Lew, John
    CELL CYCLE, 2013, 12 (13) : 1981 - 1982
  • [40] Regulation of CDK5 activity in neurons
    Hisanaga, S. I.
    Asada, A.
    Saito, T.
    NEUROSIGNALS, 2006, 15 (01) : 43 - 44